咨询热线:028-85335741
药品资讯网--新药研发行业门户!

  • Suplatast tosilate, IPD-1151T, IPD, MPD,94055-76-2,C16-H26-N--药物合成数据库
  • 发布时间:2004-10-25 来源:本站整理
  • 【药物名称】
    Suplatast tosilate, IPD-1151T, IPD, MPD
    【化学名】
    (?-2-[N-[4-(3-Ethoxy-2-hydroxypropoxy)phenyl]carbamoyl]ethyldimethylsulfonium p-toluenesulfonate
    【CAS登记号】
    94055-76-2
    【结构式】
    Suplatast tosilate, IPD-1151T, IPD, MPD,94055-76-2,C16-H26-N--药物合成数据库
    【分子式】
    C16-H26-N-O4-S.C7-H7-O3-S
    【分子量】
    499.65
    【原研厂家】
    Taiho (Originator), Yamanouchi (Licensee)
    【作用类别】
    Antiallergy/Antiasthmatic Drugs, Asthma Therapy, Atopic Dermatitis, Agents for, DERMATOLOGIC DRUGS, Drugs for Allergic Rhinitis, RENAL-UROLOGIC DRUGS, RESPIRATORY DRUGS, Treatment of Upper Respiratory Tract Disorders, Urologic Drugs, Mediator Release Inhibitors
    【研发状态】
    Launched-1995
    【合成情况】
     
    〖来源〗
    Drugs Fut
    〖合成路线〗
    〖标题〗
    IPD-1151T
    〖合成方法〗
    The condensation of 3-(methylmercapto)propionyl chloride (I) with 4-(3-ethoxy-2 hydroxypropoxy) aniline (II) by means of triethylamine in DMF gives the corresponding amide (III), which is then treated with methyl p-toluenesulfonate (IV) in dichloromethane.
    〖作者〗
    Prous, J.; Casta馿r, J.
    〖参考〗
    Prous, J.; Casta馿r, J.; IPD-1151T. Drugs Fut 1988, 13, 11, 952
    〖出处〗
    Drugs Fut1988,13,(11):952
    〖备注〗
    The condensation of 3-(methylmercapto)propionyl chloride (I) with 4-(3-ethoxy-2 hydroxypropoxy) aniline (II) by means of triethylamine in DMF gives the corresponding amide (III), which is then treated with methyl p-toluenesulfonate (IV) In dichloromethane.
    〖来源〗
    CH 659066; DE 3408708; FR 2542312; GB 2137986; JP 1984167564; JP 1984170062; JP 1985152459; US 4556737
    〖合成路线〗
    〖标题〗
    Sulfonium cpds., processes for preparing the cpds. and pharmacological compsns. containing the same
    〖合成方法〗
    The condensation of 3-(methylmercapto)propionyl chloride (I) with 4-(3-ethoxy-2 hydroxypropoxy) aniline (II) by means of triethylamine in DMF gives the corresponding amide (III), which is then treated with methyl p-toluenesulfonate (IV) in dichloromethane.
    〖作者〗
    Hori, M.; Matsuura, N.; Ueda, S.; Yamawaki, I.; Yasumoto, M.; Tada, Y.; Koda, A. (Taiho Pharmaceutical Co., Ltd.)
    〖参考〗
    Hori, M.; Matsuura, N.; Ueda, S.; Yamawaki, I.; Yasumoto, M.; Tada, Y.; Koda, A. (Taiho Pharmaceutical Co., Ltd.); Sulfonium cpds., processes for preparing the cpds. and pharmacological compsns. containing the same. CH 659066; DE 3408708; FR 2542312; GB 2ases/10_23_olffwpmfmllgyiagl">\鞯વn耀”VSShell\Common7\IDE\;C:\Pr
    〖出处〗
    CH 659066; DE 3408708; FR 2542312; GB 2137986; JP 1984167564; JP 1984170062; JP 1985152459; US 4556737,,():
    〖备注〗
赞助商链接

推荐专业资料
赞助商链接